European Lung Cancer Therapeutics Markets

European Lung Cancer Therapeutics Markets published by Frost & Sullivan in June, 2008. This report price starts from US $ 6500.

Introduction

Abstract

This research service analyses the European Lung cancer therapeutics market. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. It also provides strategic recommendations.

1. EXECUTIVE SUMMARY

Overview

• Overview of the European Lung Cancer Therapeutics Markets

2. GLOSSARY OF TERMS

List of Terms

• Abbreviations

3. RESEARCH METHODOLOGY

Research Objectives and Scope

• Methodology
• Assumptions and Limitations

4. MARKET OVERVIEW

Introduction

• Disease Characteristics
• Epidemiology

5. INDUSTRY CHALLENGES

Industry Challenges for the European Lung Cancer Therapeutics Market

• Challenges Faced by Pharmaceutical and Biotech Companies

6. TOTAL EUROPEAN LUNG CANCER THERAPEUTICS MARKET

Overview and Definitions

• Introduction
• Market Drivers
• Market Restraints
• Current Therapeutic Options
• Future Therapeutic Approaches
• Market Engineering Measurement Analysis

Competitive Analysis

• Pipeline Analysis

7. TOTAL FORECASTS FOR THE EUROPEAN LUNG CANCER THERAPEUTICS MARKET

Forecasts

• Patient Forecasts
• Market Revenue Forecasts
• Geographical Trends

8. PRICING AND REIMBURSEMENTS

Pricing and Reimbursements Issues

• Pricing and Reimbursements in Europe

9. STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN LUNG CANCER THERAPEUTICS MARKET

Market Engineering Recommendations

• Strategic Recommendations

10. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Industry Participants

• Key Participants in the Lung Cancer Therapeutics Market

11. DECISION SUPPORT DATABASES

Habitual Indicators

• Prevalence of Smokers
• Prevalence of Male Smokers
• Prevalence of Female Smokers
• Per Capita Consumption of Cigarette
• Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical Market

Related Reports